American Thoracic Society

Screen More Former Smokers for Lung Cancer, Study Suggests

May 23, 2018

Article

Data from the Mayo Clinic suggest that smokers who have quit longer than 15 years may need to be screened for lung cancer, yet they fall outside the window recommended by the United States Preventive Services Task Force.

Medicaid Expansion Linked to Decline in ICU Stays, Study at ATS Finds

May 23, 2018

Article

Researchers based at the University of Michigan compared patients admitted to the intensive care unit (ICU) in Medicaid expansion states with those in nonexpansion states, focusing on 18 specific conditions identified as severe illnesses that could be avoided through better preventive care.

Smartphones, Apps, Smart Inhalers: Using Tech to Personalize COPD Care

May 23, 2018

Article

From smartphones to smart rescue inhalers, researchers offered ideas to make chronic obstructive pulmonary disease care more data-driven and personalized.

How IMPACT Design Allowed Trelegy Ellipta to Expand Indication

May 22, 2018

Article

Navigating FDA's rules to get a fixed-dose combination therapy for chronic obstructive pulmonary disease approved required a large study and a specific population.

Legal Marijuana Industry Grows Amid Unanswered Questions for Public Health

May 22, 2018

Article

Two scientists taking part in a session on addiction and pulmonary health outlined existing evidence about marijuana's effects on chronic obstructive pulmonary disease, emphysema, chronic bronchitis, and cancer. But one speaker warned there are too few longitudinal studies in this area.

Mediterranean Diet Can Offset Harms of Breathing Polluted Air, Study Finds

May 21, 2018

Article

Results presented at the American Thoracic Society 2018 International Conference confirm a hypothesis about the connections among pollution, inflammation, and oxidative stress.

Understanding Environmental Disparities in Lung Disease—and What Can Be Done

May 21, 2018

Article

A session at the American Thoracic Society 2018 International Conference examined the factors that contribute to disparities and potential partnerships between doctors and lawyers on behalf of patients.

Long-Term Data Show One-Third of Patients Had No Exacerbations With Nucala Treatment

May 20, 2018

Article

Officials with GlaxoSmithKline said COLUMBA is the first long-term study for an anti-IL5 biologic to treat severe asthma that has been reported.

Session Explores IMPACT Details; Data Show Fewer Hospitalizations, Mortality Benefits With Triple Therapy

May 20, 2018

Article

Attendees at the American Thoracic Society 2018 International Conference, meeting in San Diego, California, heard details that led to FDA's recent expansion of the indication for GlaxoSmithKline's Trelegy Ellipta, including findings that the once-daily combination also provides significant mortality benefits over a dual therapy that is often the combination patients with chronic obstructive pulmonary disease (COPD) are taking when triple therapy is recommended.

The Affordable Care Act: Implications for Clinical Practice and Research

May 21, 2013

Article

In "What Does the Affordable Care Act Actually Do?," presented by Ivor Douglas, MD, Associate Professor, University of Colorado Denver, Chief, Pulmonary Sciences and Critical Care Medicine Director, Medical Intensive Care, Denver Health Medical Center, at the ATS 2013 International Conference, Dr Douglas noted that fundamental issues driving the Affordable Care Act (ACA) include access, quality, and cost.